|
|
||||||||
Biology of Reproduction, Vol 19, 612-619, Copyright © 1978 by Society for the Study of Reproduction
-Dihydrotestosterone on Serum Follicle
Stimulating Hormone in the Ovariectomized Rat
1 Department of Physiology and Biophysics,
University of Nebraska College of Medicine,
Omaha, Nebraska 68105 The data presented here indicate that s.c. implants of 5
-dihydrotestosterone (DHT) produce a biphasic effect on serum FSH, an
initial elevation through about 48 h followed by a decline, in rats ovariectomized as adults. Only the suppressive effects of DHT were
observed in orchidectomized rats and the stimulatory effect of DHT in ovariectomized rats was not shared by testosterone. In another
study, in which rats were gonadectomized at various ages, several days of DHT treatment suppressed serum FSH levels if ovariectomies
were performed on or before Day 8 of postnatal life, whereas serum FSH was suppressed in orchidectomized rats by DHT regardless of
the age at which orchidectomies were performed. Other results showed that the initial stimulatory effect of DHT on serum FSH in
ovariectomized rats was observed if the rats were ovariectomized on Day 9 or later. These data suggest that the development of
mechanisms responsible for a DHT-induced elevation of serum FSH in ovariectomized rats is dependent upon differentiation of the
ovarian-brain-pituitary system and occurs during the second postnatal week.
Note:
ACKNOWLEDGMENTS
We wish to express our sincere thanks to Jack
Wagoner, Sharon Clawson, Mary Alyce Vornholt,
Tim Grinbergs and Charles Berdanier for their
excellent technical assistance and to the secretarial
assistants of the department for lending us their
clerical skills. Our gratitude is also extended to Dr.
A. S. Bhatnagar, Department of Obstetrics and
Gynecology, Medical College of Virginia,
Richmond, Virginia, for computerizing the data
for us.
We wish to thank Dr. G. D. Niswender for the
LH antiserum (GN-15) and Dr. A. F. Parlow and
The Hormone Distribution Officer, National
Institute of Arthritis and Metabolic Diseases,
National Institutes of Health, Bethesda,
Maryland, 26014, for other reagents used in
radioimmunoassays.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |